Aspire Biopharma Holdings, Inc. (ASBP)
NASDAQ: ASBP · Real-Time Price · USD
5.41
-0.18 (-3.22%)
At close: May 22, 2026, 4:00 PM EDT
5.45
+0.04 (0.74%)
After-hours: May 22, 2026, 7:59 PM EDT
Aspire Biopharma Holdings Market Cap
Aspire Biopharma Holdings has a market cap or net worth of $906.01 thousand as of May 22, 2026. Its market cap has decreased by -100.00% in one year.
Market Cap
906.01K
Enterprise Value
-3.45M
1-Year Change
-100.00%
Ranking
Category
Stock Price
$5.41
Market Cap Chart
Since April 11, 2022, Aspire Biopharma Holdings's market cap has decreased from $349.64M to $906.01K, a decrease of -99.74%. That is a compound annual growth rate of -76.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 22, 2026 | 906.01K | -93.61% |
| Dec 31, 2025 | 14.18M | -84.12% |
| Dec 18, 2024 | 89.29M | -8.80% |
| Dec 29, 2023 | 97.91M | -73.55% |
| Dec 30, 2022 | 370.15M | 5.86% |
| Apr 11, 2022 | 349.64M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Valion Bio | 2.68M |
| Oragenics | 2.59M |
| SciSparc | 2.41M |
| Clearmind Medicine | 2.30M |
| Bone Biologics | 2.19M |
| Biodexa Pharmaceuticals | 2.13M |
| Silexion Therapeutics | 2.09M |
| Scinai Immunotherapeutics | 1.83M |